Study guide

8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry

Philippine Medical Technologists Licensure Examination MTLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety

1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards

2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function

2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice

3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology

3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology

4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety

4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms

5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria

5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology

6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology

6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods

7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods

7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control

8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders

8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry

9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders

9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests

10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing

10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures

11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions

11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin

12 Chapter 12: Clinical Serology and Immunology

12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)

13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology

13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control

14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens

14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens

15 Chapter 15: Histopathologic Techniques and Cytotechnology

15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records

16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics

16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics

8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry

Key Takeaways Explain This Topic AI

A wedge smear is made at a spreader angle of about 30° to 45°; a steeper angle, larger drop, or faster push gives a thicker smear.

Romanowsky stains are buffered at about pH 6.4 to 6.8; a smear that is too red reflects acidic conditions and one that is too blue reflects alkaline conditions or a thick smear.

The posterior superior iliac crest is the preferred site for bone marrow aspiration and core biopsy, and the sternum is used for aspiration only in adults.

Normal adult bone marrow has an M:E ratio of about 2:1 to 4:1 and a cellularity of about 100 minus the patient's age, ±10%.

Absent stainable marrow iron indicates iron deficiency, while ringed sideroblasts have iron granules encircling at least one-third of the nucleus.

Last updated: October 2026

Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry

Morphology of peripheral blood and bone marrow carries 20% of the Hematology blueprint. Good morphology depends on a well-made, well-stained smear and a systematic review. This section covers smear preparation, Romanowsky staining and its troubleshooting, the differential count and smear review, bone marrow aspiration and biopsy, marrow evaluation (cellularity, M:E ratio, iron stores), and the practical side of cytochemical staining.

  • 1. Preparing the Peripheral Blood Smear
  • Wedge (Push) Smear

Place a drop about 2 to 3 mm in diameter near one end of a clean slide. Bring a spreader slide back into the drop at an angle of about 30° to 45° , let the blood spread along its edge, and push forward in one smooth, steady motion.

A good smear covers about two-thirds to three-quarters of the slide, has a smooth feathered edge , and has a monolayer area just behind the feathered edge where red cells barely touch. Morphology and the differential are evaluated there.

Make smears from EDTA blood within a few hours of collection (commonly within 2 to 3 hours; sooner is better) to avoid storage artifacts such as crenated red cells and swollen, vacuolated white cells.

Controlling Smear Thickness

  • Change Effect on Smear
  • Larger drop, steeper angle, faster push Thicker, shorter smear
  • Smaller drop, flatter angle, slower push Thinner, longer smear
  • High hematocrit (polycythemia) Use a flatter angle to avoid a thick smear
  • Low hematocrit (anemia) Use a steeper angle to avoid a thin smear
  • Common Smear Defects

No feathered edge: The spreader was lifted before the end, or the drop was too large.

Ridges or uneven thickness: Jerky pushing or uneven pressure.

Holes or streaks: Dirty or greasy slides, or lipemic blood.

Smudge cells: Fragile lymphocytes broken during spreading, typical of CLL. Adding a drop of 22% albumin before making the smear reduces them.

Other Preparations

Coverslip smears (two coverslips pulled apart) give an even distribution but are rarely used now.

Spinner (centrifugal) slides and automated slide makers produce even monolayers.

Thick and thin smears for malaria: The thick smear concentrates blood to screen for parasites (red cells are lysed during staining), and the thin smear identifies the species. Thick smears must dry completely before staining.

2. Romanowsky Staining

Romanowsky stains (Wright, Giemsa, Leishman, and Wright-Giemsa) combine methylene blue and its oxidation products (azures), which are basic dyes that stain acidic structures (DNA, RNA, basophil granules) blue to purple, with eosin , an acidic dye that stains basic structures (hemoglobin, eosinophil granules) orange-red.

Wright stain contains methanol, which fixes the smear. A phosphate buffer at pH 6.4 to 6.8 is then added, and the stain develops during the buffering step.

Troubleshooting:

Problem Appearance Causes

Too acidic (too red) Red cells bright red, white cell nuclei pale, eosinophil granules bright, little blue anywhere Buffer pH too low, overwashing, too short a staining time

Too alkaline (too blue) Red cells blue-gray, everything dark, neutrophil granules too dark Buffer pH too high, thick smear, too long a staining time, inadequate washing

Stain precipitate Dark granular deposit over cells, mimicking inclusions or parasites Unfiltered or evaporated stain, slide allowed to dry during staining

Water artifact Refractile spots in red cells Moisture in the methanol or slow drying in humid air (a common problem in tropical laboratories)

3. The Differential Count and Smear Review

Low power (10×): Check stain quality and distribution, scan the feathered edge for platelet clumps , large abnormal cells, and microfilariae, and find the monolayer.

Oil immersion (100×): Classify at least 100 white cells in the monolayer using a systematic pattern (the battlement or meander track) so no field is counted twice. Report relative (%) and absolute counts (relative % × WBC count).

Red cell morphology: Grade size, color, shape, and inclusions in the monolayer.

Platelet estimate: Confirm the analyzer's count and look for giant platelets.

Correlate the smear with the CBC. A smear that does not fit the analyzer result is investigated before release.

  • 4. Bone Marrow Aspiration and Biopsy
  • Indications

Unexplained cytopenias, suspected leukemia, myelodysplasia or myeloma, staging of lymphoma and other tumors, fever of unknown origin (marrow culture for typhoid or mycobacteria, or for Leishmania and fungi), and assessment of iron stores.

Sites

Posterior superior iliac crest: The preferred site in adults and children for both aspiration and core biopsy.

Anterior iliac crest: An alternative.

Sternum: Aspiration only, in adults, because the bone is thin and the heart and great vessels lie beneath it.

Anterior medial tibia: In infants (commonly under about 1 to 2 years of age).

Specimens and Processing

Specimen How It Is Obtained What It Shows

Aspirate smears Marrow drawn into a syringe; marrow particles (spicules) spread on slides; Wright-Giemsa stained Cell morphology, differential count, M:E ratio, iron stain

  • Particle (crush) preparations Spicules squashed between slides Cellularity and megakaryocytes
  • Clot section Remaining aspirate allowed to clot, fixed, and processed in paraffin Architecture of particles

Core (trephine) biopsy A Jamshidi-type needle removes a solid core, ideally at least 1.5 to 2 cm long Cellularity, architecture, fibrosis, granulomas, metastatic tumor; decalcified (often with EDTA or formic acid) before sectioning

Touch imprints Core rolled gently on a slide before fixation Morphology when the aspirate is a dry tap

A dry tap (no marrow aspirated) suggests marrow fibrosis (primary myelofibrosis, hairy cell leukemia, metastatic tumor) or a marrow packed with cells, and makes the core biopsy and imprints essential.

5. Evaluating the Marrow

Cellularity: The proportion of marrow space occupied by hematopoietic cells rather than fat, judged on the core biopsy. A common rule of thumb is about 100 minus the patient's age, ±10% . It is very high in infants and falls with age.

Myeloid-to-erythroid (M:E) ratio: Counted on the aspirate. Normal adults have about 2:1 to 4:1 (commonly about 3:1), because granulocytes have a shorter life span and are produced in larger numbers.

Increased M:E: Infection, chronic myeloid leukemia, or erythroid hypoplasia (pure red cell aplasia).

Decreased M:E: Erythroid hyperplasia (hemolysis, blood loss, megaloblastic anemia, thalassemia, response to treatment of iron deficiency) or reduced granulopoiesis.

Megakaryocytes: Assessed for number and morphology, for example small hypolobated forms in myelodysplasia and increased megakaryocytes in immune thrombocytopenia.

Differential count: Usually 300 to 500 nucleated cells on the aspirate. Blasts of 20% or more of marrow cells define acute leukemia under WHO criteria (lower thresholds apply to some genetically defined subtypes).

Iron stores (Prussian blue / Perls stain): Storage iron in marrow macrophages is graded from absent to markedly increased. Absent stainable iron is the classic finding in iron deficiency. Ringed sideroblasts , erythroid precursors with iron granules encircling at least one-third of the nucleus, define sideroblastic anemias.

6. Practical Cytochemistry

The diagnostic reactions of each stain in acute leukemia are tabulated in the hematologic malignancy section. Practical points:

Use fresh smears (ideally within a day or two) because enzyme activity declines over time. Fixatives differ by stain (for example, formalin-based fixatives for peroxidase and buffered formalin-acetone for esterases).

Myeloperoxidase (MPO) and Sudan black B mark the granulocytic lineage. Sudan black B stains lipid and remains positive in older smears.

Specific esterase (naphthol AS-D chloroacetate) stains granulocytes. Nonspecific esterase (alpha-naphthyl acetate or butyrate) stains monocytes, and sodium fluoride inhibits the monocytic reaction.

Periodic acid-Schiff (PAS) shows glycogen, with coarse block positivity in many lymphoblasts and in abnormal erythroid precursors.

Leukocyte (neutrophil) alkaline phosphatase (LAP) score separates a leukemoid reaction (high score) from chronic myeloid leukemia (low score).

Tartrate-resistant acid phosphatase (TRAP) is positive in hairy cell leukemia; flow cytometry has largely replaced it.

Every run includes a positive control smear (normal blood for MPO and esterases), because a negative reaction is only meaningful when the stain is shown to work.